International Clinical Trial: Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808333) titled 'Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Chicago

Condition: Glaucoma, Open-angle Primary Open Angle Glaucoma (POAG)

Intervention: Drug: Nicotinamide

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: June 1, 2027

Target Sample Size: 96

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT0780...